UNIVERSAL IBOGAINE Stock Price, News & Analysis
Company Description
UNIVERSAL IBOGAINE (OTC Link: IBOGF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $4.5M.
IBOGF stock has gained 182.8% over the past year. Shares last traded at $0.0478.
This page provides a comprehensive overview of IBOGF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
UNIVERSAL IBOGAINE (IBOGF) stock last traded at $0.0478, down 4.40% from the previous close. Over the past 12 months, the stock has gained 182.8%. At a market capitalization of $4.5M, IBOGF is classified as a micro-cap stock with approximately 312.9M shares outstanding.
Latest News
UNIVERSAL IBOGAINE has 4 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences. View all IBOGF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in UNIVERSAL IBOGAINE (IBOGF) currently stands at 27.3 thousand shares, down 3.5% from the previous reporting period, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for UNIVERSAL IBOGAINE (IBOGF) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
IBOGF Company Profile & Sector Positioning
UNIVERSAL IBOGAINE (IBOGF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing IBOGF often look at related companies in the same sector, including DOSEOLOGY SCIENCES INC (DOSEF), COILED THERAPEUTICS PLC (ROQAF), BSF Enterprise PLC (BSFAF), ASEP MED HLDGS INC (SEPSF), and Core One Labs (CLABF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IBOGF's relative position within its industry.